Search Results - "Pluchino, Lenora A"

NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020 by Becker, Pamela Sue, Griffiths, Elizabeth A, Alwan, Laura M, Bachiashvili, Kimo, Brown, Anna, Cool, Rita, Curtin, Peter, Dinner, Shira, Gojo, Ivana, Hicks, Ashley, Kallam, Avyakta, Kidwai, Wajih Zaheer, Kloth, Dwight D, Kraut, Eric H, Landsburg, Daniel, Lyman, Gary H, Miller, Ryan, Mukherjee, Sudipto, Patel, Shiven, Perez, Lia E, Poust, Adam, Rampal, Raajit, Rosovsky, Rachel, Roy, Vivek, Rugo, Hope S, Shayani, Sepideh, Vasu, Sumithira, Wadleigh, Martha, Westbrook, Kelly, Westervelt, Peter, Burns, Jennifer, Keller, Jennifer, Pluchino, Lenora A

“…Management of febrile neutropenia (FN) is an integral part of supportive care for patients undergoing cancer treatment. The NCCN Guidelines for Hematopoietic…”
Get more information

National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important? by Pluchino, Lenora A., D’Amico, Thomas A.

“…The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of 28 leading cancer centers dedicated to improving and facilitating quality,…”
Get full text

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology by Ajani, Jaffer A, D'Amico, Thomas A, Bentrem, David J, Cooke, David, Corvera, Carlos, Das, Prajnan, Enzinger, Peter C, Enzler, Thomas, Farjah, Farhood, Gerdes, Hans, Gibson, Michael, Grierson, Patrick, Hofstetter, Wayne L, Ilson, David H, Jalal, Shadia, Keswani, Rajesh N, Kim, Sunnie, Kleinberg, Lawrence R, Klempner, Samuel, Lacy, Jill, Licciardi, Frank, Ly, Quan P, Matkowskyj, Kristina A, McNamara, Michael, Miller, Aaron, Mukherjee, Sarbajit, Mulcahy, Mary F, Outlaw, Darryl, Perry, Kyle A, Pimiento, Jose, Poultsides, George A, Reznik, Scott, Roses, Robert E, Strong, Vivian E, Su, Stacey, Wang, Hanlin L, Wiesner, Georgia, Willett, Christopher G, Yakoub, Danny, Yoon, Harry, McMillian, Nicole R, Pluchino, Lenora A

“…Cancers originating in the esophagus or esophagogastric junction constitute a major global health problem. Esophageal cancers are histologically classified as…”
Get more information

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology by Ajani, Jaffer A, D'Amico, Thomas A, Bentrem, David J, Chao, Joseph, Cooke, David, Corvera, Carlos, Das, Prajnan, Enzinger, Peter C, Enzler, Thomas, Fanta, Paul, Farjah, Farhood, Gerdes, Hans, Gibson, Michael K, Hochwald, Steven, Hofstetter, Wayne L, Ilson, David H, Keswani, Rajesh N, Kim, Sunnie, Kleinberg, Lawrence R, Klempner, Samuel J, Lacy, Jill, Ly, Quan P, Matkowskyj, Kristina A, McNamara, Michael, Mulcahy, Mary F, Outlaw, Darryl, Park, Haeseong, Perry, Kyle A, Pimiento, Jose, Poultsides, George A, Reznik, Scott, Roses, Robert E, Strong, Vivian E, Su, Stacey, Wang, Hanlin L, Wiesner, Georgia, Willett, Christopher G, Yakoub, Danny, Yoon, Harry, McMillian, Nicole, Pluchino, Lenora A

“…Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified…”
Get more information

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology by Ajani, Jaffer A, D'Amico, Thomas A, Bentrem, David J, Chao, Joseph, Corvera, Carlos, Das, Prajnan, Denlinger, Crystal S, Enzinger, Peter C, Fanta, Paul, Farjah, Farhood, Gerdes, Hans, Gibson, Michael, Glasgow, Robert E, Hayman, James A, Hochwald, Steven, Hofstetter, Wayne L, Ilson, David H, Jaroszewski, Dawn, Johung, Kimberly L, Keswani, Rajesh N, Kleinberg, Lawrence R, Leong, Stephen, Ly, Quan P, Matkowskyj, Kristina A, McNamara, Michael, Mulcahy, Mary F, Paluri, Ravi K, Park, Haeseong, Perry, Kyle A, Pimiento, Jose, Poultsides, George A, Roses, Robert, Strong, Vivian E, Wiesner, Georgia, Willett, Christopher G, Wright, Cameron D, McMillian, Nicole R, Pluchino, Lenora A

“…Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Squamous cell carcinoma is the most common histology in Eastern Europe and…”
Get more information

Abstract 1048: Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of drug resistance in oncogenic H-Ras-expressing bladder cancer cells by combined romidepsin and cisplatin with gemcitabine by Pluchino, Lenora A., Wang, Hwa-Chain R.

“…Abstract Human urinary bladder cancer is the fifth most commonly diagnosed cancer in the United States and is often associated with induction of oncogenic…”
Get full text

Abstract 1585: Chronic induction of breast cell carcinogenesis by multiple environmental and dietary carcinogens by Pluchino, Lenora A., Wang, Hwa-Chain R.

“…Abstract Breast cancer, the most common type of cancer among North American and European women, is mostly sporadic and attributable to long-term exposure to…”
Get full text

Abstract 5515: Combining FK228 and cisplatin synergistically induces cancer cell death and reduces clonogenic survival by Choudhary, Shambhunath, Sood, Shilpa, Pluchino, Lenora A., Wang, Hwa-Chain R.

“…Abstract The purpose of this study was to investigate the effectiveness of FK228 (romidepsin) to increase cisplatin's ability to induce cell death and reduce…”
Get full text

Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology by Gajjar, Amar, Mahajan, Anita, Abdelbaki, Mohamed, Anderson, Clarke, Antony, Reuben, Bale, Tejus, Bindra, Ranjit, Bowers, Daniel C, Cohen, Kenneth, Cole, Bonnie, Dorris, Kathleen, Ermoian, Ralph, Franson, Andrea, Helgager, Jeffrey, Landi, Daniel, Lin, Chi, Metrock, Laura, Nanda, Ronica, Palmer, Joshua, Partap, Sonia, Plant, Ashley, Pruthi, Sumit, Reynolds, Renee, Ruggieri, Paul, Stearns, Duncan, Storm, Phillip, Wang, Anthony, Warren, Katherine, Whipple, Nicholas, Zaky, Wafik, McMillian, Nicole R, Pluchino, Lenora A

“…Central nervous system (CNS) cancers account for approximately one quarter of all pediatric tumors and are the leading cause of cancer-related death in…”
Get more information

NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022 by Saad, Ayman, Loren, Alison, Bolaños-Meade, Javier, Chen, George, Couriel, Daniel, Di Stasi, Antonio, El-Jawahri, Areej, Elmariah, Hany, Farag, Sherif, Gundabolu, Krishna, Gutman, Jonathan, Ho, Vincent, Hoeg, Rasmus, Horwitz, Mitchell, Hsu, Joe, Kassim, Adetola, Kharfan Dabaja, Mohamed, Magenau, John, Martin, Thomas, Mielcarek, Marco, Moreira, Jonathan, Nakamura, Ryotaro, Nieto, Yago, Ninos, Cameron, Oliai, Caspian, Patel, Seema, Randolph, Brion, Schroeder, Mark, Tzachanis, Dimitrios, Varshavsky-Yanovsky, Asya Nina, Vusirikala, Madhuri, Algieri, Frankie, Pluchino, Lenora A

“…The NCCN Guidelines for Hematopoietic Cell Transplantation (HCT) provide an evidence- and consensus-based approach for the use of autologous and allogeneic HCT…”
Get more information